180 related articles for article (PubMed ID: 34830297)
1. CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells.
Barbera S; Raucci L; Lugano R; Tosi GM; Dimberg A; Santucci A; Galvagni F; Orlandini M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830297
[TBL] [Abstract][Full Text] [Related]
2. The C-type lectin CD93 controls endothelial cell migration via activation of the Rho family of small GTPases.
Barbera S; Lugano R; Pedalina A; Mongiat M; Santucci A; Tosi GM; Dimberg A; Galvagni F; Orlandini M
Matrix Biol; 2021 May; 99():1-17. PubMed ID: 34062268
[TBL] [Abstract][Full Text] [Related]
3. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration.
Galvagni F; Nardi F; Maida M; Bernardini G; Vannuccini S; Petraglia F; Santucci A; Orlandini M
Oncotarget; 2016 Mar; 7(9):10090-103. PubMed ID: 26848865
[TBL] [Abstract][Full Text] [Related]
4. The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration.
Barbera S; Nardi F; Elia I; Realini G; Lugano R; Santucci A; Tosi GM; Dimberg A; Galvagni F; Orlandini M
Cell Commun Signal; 2019 May; 17(1):55. PubMed ID: 31138217
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
[TBL] [Abstract][Full Text] [Related]
6. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
[TBL] [Abstract][Full Text] [Related]
7. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
Liu BP; Burridge K
Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.
Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M
Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033
[TBL] [Abstract][Full Text] [Related]
9. SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42.
Bhoopathi P; Gondi CS; Gujrati M; Dinh DH; Lakka SS
Cell Signal; 2011 Dec; 23(12):1978-87. PubMed ID: 21798346
[TBL] [Abstract][Full Text] [Related]
10. c-Cbl facilitates cytoskeletal effects in v-Abl transformed fibroblast through Rac1- and Rap1-mediated signaling.
Lee H; Gaughan JP; Tsygankov AY
Int J Biochem Cell Biol; 2008; 40(9):1930-43. PubMed ID: 18403249
[TBL] [Abstract][Full Text] [Related]
11. MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1.
Shen Q; Rahn JJ; Zhang J; Gunasekera N; Sun X; Shaw AR; Hendzel MJ; Hoffman P; Bernier A; Hugh JC
Mol Cancer Res; 2008 Apr; 6(4):555-67. PubMed ID: 18403635
[TBL] [Abstract][Full Text] [Related]
12. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
[TBL] [Abstract][Full Text] [Related]
13. Spatio-temporal co-ordination of RhoA, Rac1 and Cdc42 activation during prototypical edge protrusion and retraction dynamics.
Martin K; Reimann A; Fritz RD; Ryu H; Jeon NL; Pertz O
Sci Rep; 2016 Feb; 6():21901. PubMed ID: 26912264
[TBL] [Abstract][Full Text] [Related]
14. The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target.
Orlandini M; Galvagni F; Bardelli M; Rocchigiani M; Lentucci C; Anselmi F; Zippo A; Bini L; Oliviero S
Oncotarget; 2014 May; 5(9):2750-60. PubMed ID: 24809468
[TBL] [Abstract][Full Text] [Related]
15. Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA.
Cascone I; Giraudo E; Caccavari F; Napione L; Bertotti E; Collard JG; Serini G; Bussolino F
J Biol Chem; 2003 Dec; 278(50):50702-13. PubMed ID: 12972426
[TBL] [Abstract][Full Text] [Related]
16. PTP1B inhibitor promotes endothelial cell motility by activating the DOCK180/Rac1 pathway.
Wang Y; Yan F; Ye Q; Wu X; Jiang F
Sci Rep; 2016 Apr; 6():24111. PubMed ID: 27052191
[TBL] [Abstract][Full Text] [Related]
17. Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases.
Cox EA; Sastry SK; Huttenlocher A
Mol Biol Cell; 2001 Feb; 12(2):265-77. PubMed ID: 11179414
[TBL] [Abstract][Full Text] [Related]
18. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells.
Wojciak-Stothard B; Tsang LY; Haworth SG
Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L749-60. PubMed ID: 15591411
[TBL] [Abstract][Full Text] [Related]
19. Nadrin GAP activity is isoform- and target-specific regulated by tyrosine phosphorylation.
Beck S; Fotinos A; Gawaz M; Elvers M
Cell Signal; 2014 Sep; 26(9):1975-84. PubMed ID: 24703939
[TBL] [Abstract][Full Text] [Related]
20. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton.
Yang L; Tang L; Dai F; Meng G; Yin R; Xu X; Yao W
Toxicology; 2017 Aug; 389():74-84. PubMed ID: 28743511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
